Exelixis, Inc. News Headlines

Get EXEL Alerts
*Delayed - data as of Dec. 17, 2014  -  Find a broker to begin trading EXEL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    EXEL Pre-Market
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Filtered By
Ordered By
Will Exelixis (EXEL) Disappoint This Earnings Season? - Analyst Blog
11/3/2014 2:35:00 PM - Zacks.com

Is Exelixis, Inc. Stock a Bad News Buy?
10/13/2014 7:30:16 AM - Motley Fool

3 Biotech Stocks Near 52-Week Lows Worth Buying
10/8/2014 7:35:02 AM - Motley Fool

Roche Presents Data on Cancer Immunotherapy Candidate - Analyst Blog
10/3/2014 8:50:00 AM - Zacks.com

Exelixis (EXEL) Is in Oversold Territory: What's Next? - Tale of the Tape
10/3/2014 8:41:57 AM - Zacks.com

Big News for These 5 Stocks From ESMO
9/30/2014 8:05:02 AM - Motley Fool

Update: Exelixis Announces Very Positive Results From The CoBRIM Trial - Impacts To My Bull Thesis
9/29/2014 9:57:00 AM - Seeking Alpha

Why Exelixis, Inc. Stock Is Soaring Today
9/29/2014 9:38:30 AM - Motley Fool

Exelixis Reports Positive Results From Phase 3 Trial Of Cobimetinib
9/29/2014 3:08:00 AM - RTT News

Exelixis Reports Positive Results From Phase 3 Trial Of Cobimetinib
9/29/2014 3:08:00 AM - RTT News

Why Exelixis (EXEL) Stock Might be a Great Pick - Tale of the Tape
9/18/2014 7:53:00 AM - Zacks.com

Anika Therapeutics: A Recent Greenblatt Small Cap Biotech Pick
9/16/2014 8:38:00 AM - Seeking Alpha

Tokai Pharmaceuticals IPO: Lack Of Product Diversity Should Leave Investors Cautious
9/15/2014 8:41:00 AM - Seeking Alpha

Why Exelixis Inc. Stock Crashed By 70% in 2014
9/13/2014 9:00:02 AM - Motley Fool

Exelixis Slumps 55% on Disappointing Cabozantinib Results - Analyst Blog
9/3/2014 9:40:00 AM - Zacks.com

Exelixis (EXEL) Enters Oversold Territory - Tale of the Tape
9/3/2014 8:38:30 AM - Zacks.com

Update: Exelixis COMET-1 Trial Fails: The Impact To My Bull Thesis
9/2/2014 2:38:00 PM - Seeking Alpha

Why Exelixis Inc. Stock Plunged
9/2/2014 12:53:15 PM - Motley Fool

Exelixis Shares Slide On Trial Results; Norwegian Cruise Line Surges
9/2/2014 11:54:48 AM - Benzinga

Markets Mixed; Conn's Profit Misses Estimates
9/2/2014 10:15:49 AM - Benzinga

U.S. Stock Futures Barely Higher Before Output, Spending Data
9/2/2014 8:12:20 AM - MT Newswires

US Futures Extend Gains After Strong August as Manufacturing Data Seen Higher
9/2/2014 7:31:02 AM - MT Newswires

Exelixis, Inc.'s Not So Excellent Prostate Cancer Trial Results
9/2/2014 6:15:03 AM - Motley Fool

Can You Handle Risk? With A Dozen Clinical Trials, Exelixis Has Strong Upside Potential
8/19/2014 12:08:00 PM - Seeking Alpha

A Quick Look At 2 Small-Cap Bio-Pharmaceutical Companies: Discovery Labs And Exelexis
8/1/2014 9:22:00 PM - Seeking Alpha